These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12594846)

  • 41. HLA-B27 transgenic rats model.
    Breban M
    Ann Med Interne (Paris); 1998 Apr; 149(3):139-41. PubMed ID: 11490535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of HLA-DQ-restricted collagen-induced arthritis by HLA-DRB1 polymorphism.
    Taneja V; Griffiths MM; Luthra H; David CS
    Int Immunol; 1998 Oct; 10(10):1449-57. PubMed ID: 9796911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of genetic factors in organ-specific autoimmune diseases induced by manipulating the thymus or T cells, and not self-antigens.
    Sakaguchi S; Sakaguchi N
    Rev Immunogenet; 2000; 2(1):147-53. PubMed ID: 11324687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Markers of T lymphocyte activation in HLA-B8, DR3 positive individuals.
    Modica MA; Zambito AM; Candore G; Caruso C
    Immunobiology; 1990 Nov; 181(4-5):257-66. PubMed ID: 2129202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-human CD4 induces peripheral tolerance in a human CD4+, murine CD4-, HLA-DR+ advanced transgenic mouse model.
    Laub R; Brecht R; Dorsch M; Valey U; Wenk K; Emmrich F
    J Immunol; 2002 Sep; 169(6):2947-55. PubMed ID: 12218108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLA and H2 class II transgenic mouse models to study susceptibility and protection in autoimmune thyroid disease.
    Kong YC; Flynn JC; Wan Q; David CS
    Autoimmunity; 2003; 36(6-7):397-404. PubMed ID: 14669947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA-DQ molecules form alpha-beta heterodimers of mixed allotype.
    Kwok WW; Schwarz D; Nepom BS; Hock RA; Thurtle PS; Nepom GT
    J Immunol; 1988 Nov; 141(9):3123-7. PubMed ID: 2844907
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays.
    Johansen BH; Gjertsen HA; Vartdal F; Buus S; Thorsby E; Lundin KE; Sollid LM
    Clin Immunol Immunopathol; 1996 Jun; 79(3):288-93. PubMed ID: 8635288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA-DR/DQ transgenic, class II deficient mice as a novel model to select for HSP T cell epitopes with immunotherapeutic or preventative vaccine potential.
    Geluk A; Taneja V; van Meijgaarden KE; de Vries RR; David CS; Ottenhoff TH
    Biotherapy; 1998; 10(3):191-6. PubMed ID: 9559973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells.
    Mattapallil MJ; Silver PB; Mattapallil JJ; Horai R; Karabekian Z; McDowell JH; Chan CC; James EA; Kwok WW; Sen HN; Nussenblatt RB; David CS; Caspi RR
    J Immunol; 2011 Aug; 187(4):1977-85. PubMed ID: 21765017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA-DR modulates autoantibody repertoire, but not mortality, in a humanized mouse model of systemic lupus erythematosus.
    Paisansinsup T; Vallejo AN; Luthra H; David CS
    J Immunol; 2001 Oct; 167(7):4083-90. PubMed ID: 11564830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T-cell activation in HLA-B8, DR3-positive individuals. Early antigen expression defect in vitro.
    Candore G; Cigna D; Todaro M; De Maria R; Stassi G; Giordano C; Caruso C
    Hum Immunol; 1995 Apr; 42(4):289-94. PubMed ID: 7558912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Point mutations define positions in HLA-DR3 molecules that affect antigen presentation.
    Mellins E; Arp B; Singh D; Carreno B; Smith L; Johnson AH; Pious D
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4785-9. PubMed ID: 2112748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals.
    Stassi G; Todaro M; De Maria R; Candore G; Cigna D; Caruso C; Galluzzo A; Giordano C
    Hum Immunol; 1997 Jun; 55(1):39-45. PubMed ID: 9328788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HLA class II transgenic mice as models of human diseases.
    Taneja V; David CS
    Immunol Rev; 1999 Jun; 169():67-79. PubMed ID: 10450509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allergy to olive pollen: T-cell response from olive allergic patients is restricted by DR7-DQ2 antigens.
    Cárdaba B; De Pablo R; Vilches C; Martín E; Geller-Bernstein C; De Andrés B; Zaharan Y; Del Pozo V; Gallardo S; De Arruda Chaves E; Waisel Y; Palomino P; Kreisler M; Lahoz C
    Clin Exp Allergy; 1996 Mar; 26(3):316-22. PubMed ID: 8729669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acetylcholine receptor peptide recognition in HLA DR3-transgenic mice: in vivo responses correlate with MHC-peptide binding.
    Raju R; Spack EG; David CS
    J Immunol; 2001 Jul; 167(2):1118-24. PubMed ID: 11441124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HLA associations with autoimmune Addison's disease.
    Weetman AP; Zhang L; Tandon N; Edwards OM
    Tissue Antigens; 1991 Jul; 38(1):31-3. PubMed ID: 1926131
    [No Abstract]   [Full Text] [Related]  

  • 59. Genetic control of immune response and disease susceptibility by the HLA-DQ gene.
    Nishimura Y; Kamikawaji N; Fujisawa K; Yoshizumi H; Yasunami M; Kimura A; Sasazuki T
    Res Immunol; 1991; 142(5-6):459-66. PubMed ID: 1684444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. B and C hepatitis viruses, HLA-DQ1 and -DR3 alleles and autoimmunity in patients with hepatocellular carcinoma.
    Pellegris G; Ravagnani F; Notti P; Fissi S; Lombardo C
    J Hepatol; 2002 Apr; 36(4):521-6. PubMed ID: 11943424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.